Table 3_Elevated lactate dehydrogenase-to-albumin ratio: a novel and independent predictor

Dong Hu authored a clinical dataset analyzing the predictive ability of the lactate dehydrogenase to albumin ratio (LAR) for left ventricular aneurysm (LVA) risk in ST-segment elevation myocardial infarction (STEMI) patients. The data comprises results from three cohorts totaling 2,406 eligible participants across three medical centers in China, collected from July 2018 to 2025. Multivariate logistic regression and restricted cubic spline analyses were employed to assess the association between LAR levels and LVA risk.

Use Cases

• Developing predictive models for ventricular aneurysm based on biomarker ratios.
• Validating the LAR as an independent risk factor for cardiac complications.
• Conducting subgroup analyses to assess risk factor consistency across patient cohorts.

Strengths

• Data is derived from a multi-center study across three cohorts totaling 2,406 participants.
• Analysis includes multivariate logistic regression results with odds ratios and confidence intervals for three distinct cohorts.
• The dataset has a clear, focused research question on a novel biomarker ratio.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count for the specific table is unknown, which may limit suitability assessment.
• Data may reflect geographic and temporal bias inherent to the three Chinese medical centers and the 2018-2025 study period.

Provenance

Source

Dong Hu via figshare.

Collection Method

Clinical study data from STEMI patients undergoing primary percutaneous coronary intervention.

Time Range

July 2018 to 2025.

Freshness

Last updated 2026-05-13 04:30:16; freshness should be verified.

Geography

Three medical centers in China.